06RB4JZ
Replacement Renal Vein, Left to No Qualifier with Synthetic Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 6 Lower Veins |
| Operation | R Replacement |
| Body Part | B Renal Vein, Left |
| Approach | 4 Percutaneous Endoscopic |
| Device | J Synthetic Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically takes the place and/or function of all or a portion of a body part
Procedure Overview
This family covers procedures where a diseased or damaged segment of a lower-body vein - in the leg, pelvis, or abdomen - is physically removed and replaced with another material that takes over its job of carrying blood back toward the heart. The replacement material can be a graft harvested from the patient's own body, tissue from a donor or animal source that has been processed for implantation, or a synthetic conduit made from materials like expanded PTFE. It is most often considered when a vein segment is too scarred, obstructed, or aneurysmal to repair in place.
Surgeons turn to this approach in situations such as reconstructing a badly damaged femoral or iliac vein after trauma, cancer resection that required removing a vein along with a tumor, or chronic venous disease that has destroyed a segment beyond salvage. The goal is to restore a functioning channel for venous return rather than simply tying off the vessel, which can be important for preventing long-term swelling and pressure buildup in the limb.
Because deep veins carry a large volume of blood at low pressure, these reconstructions are technically demanding and are typically reserved for cases where the alternative - vein ligation or leaving the segment untreated - would cause significant disability.
Anatomy & Axis Detail
Renal Vein, Left
The left renal vein is longer than its right-sided counterpart, coursing anterior to the aorta and receiving the left gonadal and adrenal veins before draining into the inferior vena cava, features that make it both a common surgical landmark and a vessel occasionally sacrificed or reconstructed during aortic or retroperitoneal tumor surgery. Replacement is typically undertaken when a segment is resected for direct tumor invasion, most often from renal cell carcinoma or retroperitoneal sarcoma, or following traumatic transection, with a graft used to preserve venous outflow from the left kidney and its tributaries. Because ligation of the left renal vein is sometimes tolerated due to collateral drainage, a documented replacement indicates a deliberate effort to preserve renal function through graft reconstruction.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Synthetic Substitute
Synthetic Substitute designates a device made from manufactured, non-biologic material, such as mesh or prosthetic components, used to replace or augment a body part. It is distinguished from the two tissue substitute categories by its artificial composition, which carries different considerations for integration and long-term durability than biologic grafts.
Coding & Documentation
A code from this family requires documentation that a vein segment was excised or entirely taken out of the body and replaced with graft material, not simply patched, bypassed, or reinforced on its outer surface. The operative note should specify the exact vein involved (e.g., common femoral vein versus external iliac vein) and the type of material used, since device value selection depends on whether the graft is autologous tissue, nonautologous tissue, or synthetic.
The most common assignment error is confusing Replacement with Supplement or Bypass. If the native vein is left in place and the graft material is only added to reinforce or widen it, Supplement applies instead. If the graft creates an alternate route around a blocked segment while the diseased vein remains, that is a Bypass procedure, not Replacement. Coders should also confirm the qualifier for autologous versus nonautologous tissue, which is frequently omitted or guessed rather than confirmed from the documentation.